Evidence map›Paper›PMID 34577171›Full record

ReviewMolecules (Basel, Switzerland)2021

Ginger, a Possible Candidate for the Treatment of Dementias?

Giovanni Schepici, Valentina Contestabile, Andrea Valeri, Emanuela Mazzon

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pharmacological properties of ginger (Frontiers in pharmacology · 2025
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Effects of Ginger (Biomolecules · 2024
    Review
  6. Nutritional aphrodisiacs: Biochemistry and Pharmacology.Current research in food science · 2024
    Review
  7. Review
  8. Article
  9. Elucidating the Beneficial Effects of Ginger (ACS pharmacology & translational science · 2022
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Giovanni SchepiciIRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.
Valentina ContestabileIRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.
Andrea ValeriIRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.ORCID 0000-0002-1457-1619
Emanuela MazzonIRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.

Funding

Ministero della Salute Current Research Funds 2021
6 · The paper itself

Abstract

As the human life expectancy increases, age-linked diseases have become more and more frequent. The worldwide increment of dementia cases demands medical solutions, but the current available drugs do not meet all the expectations. Recently the attention of the scientific community was attracted by natural compounds, used in ancient medicine, known for their beneficial effects and high tolerability. This review is focused on Ginger (

Indexed as

CatecholsDementiaDrug DiscoveryFatty AlcoholsGuaiacolHumansKetonesModels, MolecularPlant ExtractsProtective AgentsSesquiterpenesStructure-Activity RelationshipZingiber officinale6-paradolCatecholsFatty AlcoholsgingerolGuaiacolKetonesPlant ExtractsProtective AgentsSesquiterpenesshogaolzerumbonezingeroneAlzheimer’s diseasedementiagingerneurodegenerationneuroinflammationneuroprotectionvascular dementia

Identifiers

PMID34577171
PMCPMC8470323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.